切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2019, Vol. 13 ›› Issue (01) : 73 -77. doi: 10.3877/cma.j.issn.1674-134X.2019.01.014

所属专题: 文献

荟萃研究

一期和二期髋关节翻修术后感染复发率的Meta分析
林丽能1, 王辉2, 孙效棠2, 张志宏2, 王万明2,()   
  1. 1. 350000 福州,福建医科大学;361101 厦门市第五医院骨关节科
    2. 350001 福州,联勤保障部队第九〇〇医院(原南京军区福州总医院)骨二科
  • 收稿日期:2017-05-19 出版日期:2019-02-01
  • 通信作者: 王万明
  • 基金资助:
    军委后勤保障重大项目(AWS16J032)

Meta analysis on re-infection following one and two stage revisions of infected total hip arthroplasty

Lineng Lin1, Hui Wang2, Xiaotang Sun2, Zhihong Zhang2, Wanming Wang2,()   

  1. 1. Fujian Medical University, Fuzhou 350000, China; The Fifth Hospital of Xiamen, Xiamen 361101, China
    2. 900 Hospital of the Joint Logistics Team(Fuzhou General Hospital of Nanjing military command), Fuzhou 350001, China
  • Received:2017-05-19 Published:2019-02-01
  • Corresponding author: Wanming Wang
  • About author:
    Corresponding author: Wang Wanming, Email:
引用本文:

林丽能, 王辉, 孙效棠, 张志宏, 王万明. 一期和二期髋关节翻修术后感染复发率的Meta分析[J/OL]. 中华关节外科杂志(电子版), 2019, 13(01): 73-77.

Lineng Lin, Hui Wang, Xiaotang Sun, Zhihong Zhang, Wanming Wang. Meta analysis on re-infection following one and two stage revisions of infected total hip arthroplasty[J/OL]. Chinese Journal of Joint Surgery(Electronic Edition), 2019, 13(01): 73-77.

目的

比较一期和二期翻修术治疗全髋关节置换术(THA)后感染的感染复发率。

方法

在Pubmed、EMBase和Medline(1988年1月到2017年1月)3个数据库进行检索。收集THA术后感染行一期和二期翻修的文章。筛选符合预先设定标准(一期翻修与二期翻修对照治疗全髋关节置换术后感染,排除非对照研究)的文章,提取手术例数及感染复发例数进行Meta分析。采用Review Manager 5.3软件统计分析感染复发率。

结果

初检1 084篇,最终纳入10篇。THA术后感染总共1 116例,其中一期翻修480例,二期翻修636例;一期和二期的感染复发率对比结果为[OR = 1.40,95%CI(0.92,2.15),P =0.12]。如果将软组织情况良好、骨缺损少、致病菌明确且对药物敏感作为一期翻修的选择条件,一期和二期翻修的感染复发率相似,结果无统计学意义[OR=0.44,95%CI(0.13,1.41),P =0.17];对于THA术后感染,如果不考虑软组织、骨缺损、致病菌的情况下行翻修手术,二期翻修的感染复发率比一期低,结果具有统计学意义[OR =1.79,95%CI(1.11,2.88),P =0.02]。

结论

对于THA术后感染的治疗,局部条件良好与否会影响一期和二期翻修术后感染复发率。

Objective

To compare the re-infection of infected total hip arthroplasty (THA) treated by one stage revision and two sate revision.

Methods

The papers about THA treated by one stage and two stage revision were searched on Pubmed、Medline and EMBase data(January, 1988 to Jananuary, 2017). The papers were selected according to the criteria(the papers about THA treated by one stage and two stage revisions, excluding treated by single treatment). The re-infection rate was analysed by meta-analysis. Review Manger 5.3 was used for data analysis.

Results

Ten articles were collected from 1 084 articles finally. 1 116 cases infected THA were studied, which 480 cases were treated by one-stage revision and 636 cases were treated by two-stage revision. Re-infection rate between the two group results shows[OR=1.40, 95%CI(0.92, 2.15), P =0.12]. If the soft tissue was healthy、the bone defect was small and the pathogen was determined, the re-infection rates were similar between one stage and two stage revisions[OR=0.44, 95%CI(0.13, 1.41), P =0.17]; If the soft tissue、bone defects and pathogens were not considered, the difference in the re-infection rate was statistically significant [OR=1.79, 95%CI(1.11, 2.88), P=0.02].

Conclusion

In the treatment of the infected total hip arthroplasty, the local condition may influence the re-infection rate of one-stage and two stage revision surgery.

图1 发表偏倚漏斗图
表1 纳入文献基本信息
图2 髋关节置换术后感染一期和二期翻修感染复发率对比。亚组分析,亚组A按软组织好、骨缺损少、病原体明确作为一期翻修的选择依据,亚组B未对翻修病例进行选择
[1]
陶庆梅,徐荣彬,杨俊等. 人工髋关节置换术主要不良事件发生率的Meta分析[J]. 药物流行病学杂志,2016(5):275-280.
[2]
Kliushin NM, Ermakov AM, Malkova TA. Chronic periprosthetic hip infection:micro-organisms responsible for infection and re-infection[J]. Int Orthop, 2016:1-7.
[3]
Mah TF, Pitts B, Pellock B, et al. A genetic basis for pseudomonas aeruginosa biofilm antibiotic resistance[J]. Nature, 2003, 426(6964): 306-310.
[4]
Schwarzkopf R, Mikhael B, Wright E, et al. Treatment failure among infected periprosthetic total hip arthroplasty patients[J]. Open Orthop J, 2014, 8(1):118-124.
[5]
Fink B. Revision of late periprosthetic infections of total hip endoprostheses: pros and cons of different concepts[J]. Int J Med Scis, 2009, 6(5):287-295.
[6]
Berend KR, Jr LA, Morris MJ, et al. Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality[J]. Clin Orthop Relat R, 2013, 471(2):510-518.
[7]
Zeller V, Lhotellier L, Marmor S, et al. One-stage exchange arthroplasty for chronic periprosthetic hip infection: results of a large prospective cohort study[J]. J Bone Joint Surg, 2014, 96(1):e1(1-9).
[8]
Ilchmann T, Zimmerli W, Ochsner PE, et al. One-stage revision of infected hip arthroplasty: outcome of 39 consecutive hips[J]. Int Orthop, 2016, 40(5):913-918.
[9]
George D A, Konan S, Haddad F S. single-stage hip and knee exchange for periprosthetic joint infection[J]. J Arthrop, 2015, 30(12):2264-2270.
[10]
郑明华. Meta分析软件应用与实例解析[M]. 人民卫生出版社,第1版,2013, 77-78.
[11]
Wells GA, Shea BJ, O’Connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis[J]. Appl Eng Agric, 2000, 18(6):727-734.
[12]
Born P, Ilchmann T, Zimmerli W, et al. Eradication of infection, survival, and radiological results of uncemented revision stems in infected total hip arthroplasties: 28 one-stage and 53 two-stage exchanges with a mean follow-up of 7 years[J].Acta Orthop, 2016, 87(6):637-643.
[13]
Choi HR, Kwon YM, Freiberg AA, et al. Comparison of one-stage revision with antibiotic cement versus two-stage revision results for infected total hip arthroplasty[J]. J Arthrop, 2013, 28(8):66-70.
[14]
De Man FH, Sendi P, Zimmerli W, et al. Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm.[J]. Acta Orthop, 2011, 82(1):27-34.
[15]
Engesater LB, Dale H, Schrama JC, et al. Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register[J]. Acta Orthop, 2011, 82(5):530-537.
[16]
Giulieri SG, Graber P, Ochsner PE, et al. Management of infection associated with total hip arthroplasty according to a treatment algorithm[J]. Infection, 2004, 32(4):222-228.
[17]
Hope PG, Kristinsson KG, Norman P, et al. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci[J]. J Bone Joint Surg, 1989, 71(5):851-855.
[18]
Klouche S, Leonard P, Zeller V, et al. Infected total hip arthroplasty revision: one-or two-stage procedure?[J]. Orthop Traumatol Surg R, 2012, 98(2):144-150.
[19]
Morscher E, Babst R, Jenny H. Treatment of infected joint arthroplasty[J]. Int Orthop, 1990, 14(2):161-165.
[20]
Oussedik SI, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol[J]. J Bone Joint Surg, 2010, 92(9):1222-1226.
[21]
Wolf M, Clar H, Leithner A, et al. Prosthetic joint infection following total hip replacement[J]. Int Orthop, 2014, 38(11):1363–1368.
[22]
Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement: current concepts[J]. Clin Orthop Relat R, 1984, 190:96-108.
[23]
Cohen JC, Hozack WJ, Cuckler JM, et al. Two-stage reimplantation of septic total knee arthroplasty. Report of three cases using an antibiotic-PMMA spacer block[J]. J Arthrop, 1988, 3(4):369-377.
[24]
Azzam K, Parvizi J, Jungkind D, et al. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience[J]. J Bone Joint Surg, 2009, 91 Suppl 6(6):142-149.
[25]
Whiteside LA, Roy ME. One-stage revision with catheter infusion of intra-articular antibiotics successfully treats infected THA[J]. Clin Orthop Relat R, 2017, 475(2):419-429.
[26]
Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections[J]. J Bone Joint Surg, 1996, 78(4):512-523.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[3] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[4] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[5] 顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[6] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[7] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[8] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[9] 王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.
[10] 董大红, 周明虎, 李芝朋, 许正峰. 碳青霉烯类抗生素联合呼吸机治疗肺部感染的临床疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 793-796.
[11] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[12] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[13] 王芳, 刘达, 左智炜, 盛金平, 陈庭进, 蒋锐. 定量CT与双能X线骨密度仪对骨质疏松诊断效能比较的Meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 363-371.
[14] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要